Teton Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History

Teton Advisors’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-26,000	Closed	-$129K	–	403
2021 Q1	$129K	Hold	26,000	–	–	0.02%	369
2020 Q4	$112K	Hold	26,000	–	–	0.02%	378
2020 Q3	$112K	Sell	26,000 -10,000	-28%	-$41.8K	0.02%	364
2020 Q2	$162K	Hold	36,000	–	–	0.03%	362
2020 Q1	$144K	Hold	36,000	–	–	0.02%	378
2019 Q4	$305K	Hold	36,000	–	–	0.03%	390
2019 Q3	$247K	Buy	36,000 +2,000	+6%	+$14.7K	0.03%	406
2019 Q2	$283K	Buy	34,000 +17,000	+100%	+$147K	0.03%	402
2019 Q1	$156K	Buy	17,000 +4,000	+31%	+$40.6K	0.02%	443
2018 Q4	$142K	Buy	+13,000	New	+$164K	0.02%	438

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Teton Advisors's KIN Position: Q2 2021 in Review

Teton Advisors sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 26,000 shares — an estimated $129K sold.

Teton Advisors first reported a position in KIN in Q4 2018 and held it in 10 quarters. The position peaked at $305K in Q4 2019. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

Teton Advisors reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
Teton Advisors sold 26,000 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $129K.
Teton Advisors first reported a position in Kindred Biosciences, Inc. in Q4 2018 and held it in 10 quarters.
Teton Advisors's Kindred Biosciences, Inc. position peaked at $305K in Q4 2019.
87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Teton Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.